Vincenza Nigro
Corporate Officer/Principal bij HANSA BIOPHARMA AB
Actieve functies van Vincenza Nigro
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 17-09-2018 | - |
| Hoofd Techniek/Wetenschap/O&O | 17-09-2018 | - |
Loopbaan van Vincenza Nigro
Eerdere bekende functies van Vincenza Nigro
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Vincenza Nigro
| Fairleigh Dickinson University | Undergraduate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Denemarken | 2 |
| Zweden | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Beurs
- Insiders
- Vincenza Nigro
- Ervaring